Pelthos Therapeutics Inc. (NYSEAM: PTHS)
Health Care · Biotechnology · US
$20.29
-1.02% today · -11.4% 1Y
Pelthos Therapeutics Inc. (NYSEAM: PTHS) operates in the Biotechnology industry within the Health Care sector. The company is valued at $78.48M and employs 92 people.
Over the last twelve months the share price has lost 11.4%, trading between 18.19 and 37.50.
Tweenvest scores Pelthos Therapeutics Inc. across four factors: quality 29/100, value 65/100. Its strongest factor is value.
PTHS price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $78.48M
- Revenue (TTM)
- $43.30M
- P/E
- —
- EPS
- -26.36
- Dividend yield
- —
- Beta (5Y)
- 3.11
- 52-week high
- $37.50
- 52-week low
- $18.19
- Avg volume (3M)
- —
- Shares outstanding
- 3.83M
- Employees
- 92
- Next earnings
- —
About Pelthos Therapeutics Inc.
Pelthos Therapeutics Inc. operates as a biopharmaceutical enterprise dedicated to developing and commercializing innovative medical treatments that address significant, unmet patient needs. Its primary offerings include ZELSUVMI, a medication specifically indicated for the treatment of molluscum contagiosum in individuals aged one year and older. Furthermore, the company leverages NITRICIL, an exclusive technological platform grounded in nitric oxide research. Established in 2002, this Durham, North Carolina-based firm was previously known as Channel Therapeutics Corporation, before rebranding to Pelthos Therapeutics Inc. in July 2025.
- ISIN
- US1711262048
- Founded
- 2002
- Listed since
- Feb 16, 2024
- Exchange
- NYSE American LLC
- Currency
- USD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| GlycoNex IncorporationTPEX: 4168 | $80.23M | NT$22.80 | +1.79% |
| BioPorto A/SCPSE: BIOPOR | $79.36M | Dkr1.04 | -2.80% |
| Nordicus Partners CorporationOTCPK: NORD | $79.33M | $4.08 | +1.77% |
| Brii Biosciences LimitedSEHK: 2137 | $79.11M | HK$0.86 | -3.37% |
| Cell Biotech Co., Ltd.KOSDAQ: A049960 | $78.19M | ₩15,360.00 | -1.54% |
| CORESTEMCHEMON Inc.KOSDAQ: A166480 | $77.21M | ₩2,340.00 | +1.08% |
| Heron Therapeutics, Inc.NasdaqCM: HRTX | $77.10M | $0.39 | -3.82% |
| Covalon Technologies Ltd.TSXV: COV | $76.84M | CA$4.10 | +3.27% |
Figures last refreshed Oct 11, 2026.